Literature DB >> 15025571

Native antiviral specificity of chicken Mx protein depends on amino acid variation at position 631.

J H Ko1, A Takada, T Mitsuhashi, T Agui, T Watanabe.   

Abstract

An attempt was made to determine whether amino acid variation at position 631 in the chicken Mx protein definitely influences antiviral specificity, using an artificial mutation technique by which a single amino acid was reciprocally substituted between Ser (AGT) and Asn (AAT) at position 631 of the negative and positive chicken Mx, respectively. Using permanently transfected 3T3 cell lines, the antiviral potential of chicken Mx against vesicular stomatitis virus infection was analysed. The results indicated that the phenotype of antiviral activity depends on the amino acid difference at position 631; that is, the genotype coding Asn at position 631 corresponds to the positive antiviral phenotype, and the genotype coding Ser corresponds to the negative phenotype. The present study has confirmed that the antiviral specificity of chicken Mx protein is determined by an amino acid substitution at the carboxy terminus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15025571     DOI: 10.1111/j.1365-2052.2004.01096.x

Source DB:  PubMed          Journal:  Anim Genet        ISSN: 0268-9146            Impact factor:   3.169


  22 in total

1.  Mx is dispensable for interferon-mediated resistance of chicken cells against influenza A virus.

Authors:  Benjamin Schusser; Antje Reuter; Alexander von der Malsburg; Nicola Penski; Steffen Weigend; Bernd Kaspers; Peter Staeheli; Sonja Härtle
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Association of Mx1 Asn631 variant alleles with reductions in morbidity, early mortality, viral shedding, and cytokine responses in chickens infected with a highly pathogenic avian influenza virus.

Authors:  Sandra J Ewald; Darrell R Kapczynski; Emily J Livant; David L Suarez; John Ralph; Scott McLeod; Carolyn Miller
Journal:  Immunogenetics       Date:  2011-02-01       Impact factor: 2.846

3.  Positive diversifying selection in avian Mx genes.

Authors:  Sofia Berlin; Lujiang Qu; Xianyao Li; Ning Yang; Hans Ellegren
Journal:  Immunogenetics       Date:  2008-08-26       Impact factor: 2.846

Review 4.  Mx proteins: antiviral gatekeepers that restrain the uninvited.

Authors:  Judith Verhelst; Paco Hulpiau; Xavier Saelens
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

5.  Mx gene diversity and influenza association among five wild dabbling duck species (Anas spp.) in Alaska.

Authors:  Danielle Dillon; Jonathan Runstadler
Journal:  Infect Genet Evol       Date:  2010-07-16       Impact factor: 3.342

6.  Partial antiviral activities of the Asn631 chicken Mx against newcastle disease virus and vesicular stomatitis virus.

Authors:  Bichun Li; Dezhi Fu; Yani Zhang; Qi Xu; Ligang Ni; Guobin Chang; Mengmeng Zheng; Bo Gao; Huaichang Sun; Guohong Chen
Journal:  Mol Biol Rep       Date:  2012-06-19       Impact factor: 2.316

7.  Identification of avian RIG-I responsive genes during influenza infection.

Authors:  Megan R W Barber; Jerry R Aldridge; Ximena Fleming-Canepa; Yong-Dong Wang; Robert G Webster; Katharine E Magor
Journal:  Mol Immunol       Date:  2012-12-04       Impact factor: 4.407

8.  Genotype frequency contributions of Mx1 gene in eight chicken breeds under different selection pressures.

Authors:  Jingjing Li; Chaowu Yang; Jinshan Ran; Xiaosong Jiang; Huarui Du; Zhiqiang Li; Yiping Liu; Long Zhang
Journal:  3 Biotech       Date:  2018-11-14       Impact factor: 2.406

9.  Asparagine 631 variants of the chicken Mx protein do not inhibit influenza virus replication in primary chicken embryo fibroblasts or in vitro surrogate assays.

Authors:  Camilla T O Benfield; Jon W Lyall; Georg Kochs; Laurence S Tiley
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

10.  Evolutionary repercussions of avian culling on host resistance and influenza virulence.

Authors:  Eunha Shim; Alison P Galvani
Journal:  PLoS One       Date:  2009-05-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.